Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein

• Published in: Avian diseases Vol. 36; no. 4; p. 858
• Main Authors: Morgan, R.W, Gelb, J. Jr, Schreurs, C.S, Lutticken, D, Rosenberger, J.K, Sondermeijer, P.J.A
• Format: Journal Article
• Language: English
• Published: United States 01.10.1992
• Subjects: Animals; Chickens - immunology; Chickens - microbiology; CONTROL DE ENFERMEDADES; CONTROLE DE MALADIES; Herpesviridae; HERPETOVIRIDAE; Marek Disease - immunology; Marek Disease - prevention & control; Newcastle Disease - immunology; Newcastle Disease - prevention & control; POLLO; POULET; Poultry Diseases - immunology; Poultry Diseases - prevention & control; Turkeys - microbiology; VACCIN SYNTHETIQUE; VACCINATION; Vaccines, Synthetic - genetics; Vaccines, Synthetic - immunology; VACUNA SINTETICA; VACUNACION; Viral Fusion Proteins - genetics; Viral Fusion Proteins - immunology; Viral Vaccines - genetics; Viral Vaccines - immunology; Viremia - prevention & control; Viremia - veterinary; VIRUS DE LA ENFERMEDAD DE NEWCASTLE; VIRUS MALADIE DE NEWCASTLE
• ISSN: 0005-2086; 1938-4351
• DOI: 10.2307/1591544

Recombinant strains of herpesvirus of turkeys (HVT) were constructed that contain either the fusion protein gene or the hemagglutinin-neuraminidase gene of Newcastle disease virus (NDV) inserted into a nonessential gene of HVT. Expression of the NDV antigens was regulated from a strong promoter element derived from the Rous sarcoma virus long terminal repeat. Recombinant HVT strains were stable and fully infectious in cell culture and in chickens. Chickens receiving a single intra-abdominal inoculation at 1 day of age with recombinant HVT expressing the NDV fusion protein had an immunological response and were protected (90%) against lethal intramuscular challenge at 28 days of age with the neurotropic velogenic NDV strain Texas GB. Recombinant HVT expressing the NDV hemagglutinin-neuraminidase provided partial protection (47%) against the same challenge. Chickens vaccinated with recombinant HVT vaccines had low levels of protection against NDV replication in the trachea when challenged ocularly. Recombinant HVT vaccines and the parent HVT strain provided similar levels of protection to chickens challenged with the very virulent RB1B strain of Marek's disease virus, indicating that insertion of foreign sequences into the HVT genome did not compromise the ability of HVT to protect against Marek's disease